The best of cardiac imaging 2002;L'essentiel de 2002 en cardiologie nucléaire et IRM

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue SPEC. ISS. 1, 2003, Pages 73-85

  Manrique, A ^a   Marie, P Y ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; TETROFOSMIN; THALLIUM 201;

ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DRUG EFFECT; EVALUATION; EVIDENCE BASED MEDICINE; GATED IMAGING; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PERFUSION; HEART VOLUME; HUMAN; IMAGE ANALYSIS; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RADIOLOGIST; REVIEW; SCREENING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION; TECHNIQUE; TECHNOLOGY; TOMOSCINTIGRAPHY; VALIDATION PROCESS;

EID: 0037255082     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Nichols K, Santana CA, Folks R et al. Comparison between ECTb and QGS for assessment of left ventricular function from gated myocardial perfusion SPECT. J Nucl Cardiol 2002; 9: 85-93.
2. Germano G, Kiat H, Kavanagh P et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-47.
3. Fleming RM. High-dose dipyridamole and gated sestamibi SPECT imaging provide diagnostic resting and stress ejection fractions useful for predicting extent of coronary artery disease. Angiology 2002; 53: 415-21.
4. Emmett L, Iwanochko RM, Freeman MR, Barolet A, Lee DS, Husain M. Reversible regional wall motion abnormalities on exercise technetium-99m-gated cardiac single photon emission computed tomography predict high-rade angiographic stenoses. J Am Col Cardiol 2002; 39: 991-8.
5. Santiago FY, Heiba SI, Jana S, Mirzaitehrane M, Dede F, Abdel-Dayem HM. Transient ischemic stunning of the myocardium in stress thallium-201 gated SPET myocardial perfusion imaging: segmental analysis of myocardial perfusion wall motion and wall thickening changes. Eur J Nucl Med Mol Imaging 2002; 29: 979-83.
6. Paul AK, Hasegawa S, Yoshioka J et al. Characteristics of regional myocardial stunning after exercise in gated myocardial SPECT. J Nucl Cardiol 2002; 9: 388-94.
7. Yamagishi H, Shirai N, Yoshiyama M, et al. Incremental value of left ventricular ejection fraction for detection of multivessel coronary artery disease in exercise (201)TI gated myocardial perfusion imaging. J Nucl Med 2002; 43: 191-9.
8. Shirai N, Yamagishi H, Yoshiyama M et al. Incremental value of assessment of regional wall motion for detection of multivessel coronary artery disease in exercise (201)TI gated myocardial perfusion imaging. J Nucl Med 2002; 43: 443-50.
9. Taki J, Higuchi T, Nakajima K et al. Electrocardiographic gated (99m)Tc-MIBI SPECT for functional assessment of patients after coronary artery bypass surgery: comparison of wall thickening and wall motion analysis. J Nucl Med 2002; 43: 589-95.
10. Danias PG, Ahlberg AW, Travin MI et al. Visual assessment of left ventricular perfusion and function with electrocardiographygated SPECT has high intraobserver and interobserver reproducibility among experienced nuclear cardiologists and cardiology trainees. J Nucl Cardiol 2002; 9: 263-70.
11. Everaert H, Vanhove C, Franken PR. Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies. Eur J Nucl Med 1999; 26: 1298-303.
12. Everaert H, Vanhove C, Franken PR. Low-dose dobutamine gated single-photon emission tomography: comparison with stress echocardiography. Eur J Nucl Med 2000; 27: 413-8.
13. Leoncini M, Marcucci G, Sciagra R et al. Nitrate-enhanced gated technetium 99m sestamibi SPECT for evaluating regional wall motion at baseline and during low-dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction: comparison with two-dimensional echocardiography. J Nucl Cardiol 2000; 7: 426-31.
14. Leoncini M, Marcucci G, Sciagra R et al. Prediction of functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction combining the evaluation of myocardial perfusion and of contractile reserve using nitrate-enhanced technetium-99m sestamibi gated single-photon emission computed tomography and dobutamine stress. Am J Cardiol 2001; 87: 1346-50.
15. Leoncini M, Sciagra R, Maioli M et al. Usefulness of dobutamine Tc-99m sestamibi-gated single-photon emission computed tomography for prediction of left ventricular ejection fraction outcome after coronary revascularization for ischemic cardiomyopathy. Am J Cardiol 2002; 89: 817-21.
16. Yamagishi H, Akioka K, Hirata K et al. Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium. J Nucl Cardiol 2001; 8: 58-67.
17. Yoshinaga K, Morita K, Yamada S et al. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET. J Nucl Med 2001; 42: 838-44.
18. Chin BB, Esposito G, Kraitchman DL. Myocardial contractile reserve and perfusion defect severity with rest and stress dobutamine (99m)Tc-sestamibi SPECT in canine stunning and subendocardial infarction. J Nucl Med 2002; 43: 540-50.
19. Simoes MV, de Almeida-Filho OC, Pintya AO et al. Prediction of left ventricular wall motion recovery after acute myocardial infarction by TI-201 gated SPECT: incremental value of integrated contractile reserve assessment. J Nucl Cardiol 2002; 9: 294-303.
20. Kapur A, Latus K, Davies G et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur J Nucl Med 2002 (in press).
21. Links JM, DePuey EG, Taillefer R, Becker LC. Attenuation correction and gating synergistically improve the diagnostic accuracy of myocardial perfusion SPECT. J Nucl Cardiol 2002; 9: 183-7.
22. Gibson PB, Demus D, Noto R, Hudson W, Johnson LL. Low event rate for stress-only perfusion imaging in patients evaluated for chest pain. J Am Coll Cardiol 2002; 39: 999-1004.
23. Daou D, Delahaye N, Vilain D, Lebtahi R, Faraggi M, Le Guludec D. Identification of extensive coronary artery disease: incremental value of exercise TI-201 SPECT to clinical and stress test variables. J Nucl Cardiol 2002; 9: 161-8.
24. Tsou SS, Shiau YC, Kao CH, Lin CC, Lee CC. Lung uptake of technetium-99m tetrofosmin in healthy subjects is related to smoking habits. Cardiology 2002; 97: 99-103.
25. Franchini M, Traversi E, Cannizzaro G, Cobelli F, Pozzoli M. Dobutamine stress echocardiography and thallium-201 SPECT for detecting ischaemic dilated cardiomyopathy in patients with heart failure. Eur J Echocardiogr 2000; 1: 109-15.
26. Parthenakis FI, Prassopoulos VK, Koukouraki SI et al. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities. J Nucl Cardiol 2002; 9: 15-22.
27. Hassan N, Escanye JM, Juilliere Y et al. 201 TI SPECT abnormalities, documented at rest in dilated cardiomyopathy, are related to a lower than normal myocardial thickness but not to an excess in myocardial wall stress. J Nucl Med 2002; 43: 451-7.
28. Hachamovitch R, Berman DS, Kiat H, Cohen I, Friedman JD, Shaw U. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002; 105: 823-9.
29. De Lorenzo A, Lima R, Siqueira-Filho A, Pantoja M. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002; 90: 827.
30. Giri S, Shaw U, Murthy DR et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002; 105: 32-40.
31. Allman KC, Shaw U, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunctian: a meta-analysis. J Am Coll Cordial 2002; 39: 1151-8.
32. Podio V, Spinnler MT, Bertuccio G, Carbonero C, Pelosi E, Bisi G. Prognosis of hibernating myocardium is independent of recovery of function: evidence from a routine based follow-up study. Nucl Med Commun 2002; 23: 933-42.
33. Acampa W, Cuocolo A, Petretta M et al. Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi anti TI-201 scintigraphy. J Nucl Cardiol 2002; 9: 33-40.
34. de Groote P, Millaire A, Foucher-Hossein C et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998; 32: 948-54.
35. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995; 25: 1143-53.
36. Juilliere Y, Barbier G, Feldmann L, Grentzinger A, Danchin N, Cherrier F. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 1997; 18: 276-80.
37. Bartlett ML, Seaton D, McEwan L, Fong W. Determination of right ventricular ejection fraction from reprojected gated blood pool SPET: comparison with first-pass ventriculography. Eur J Nucl Med 2001; 28: 608-13.
38. Johnson LL, Lawson MA, Blackwell GG, Tauxe EL, Russell K, Dell'Italia LJ. Optimizing the method to calculate right ventricular ejection fraction from first-pass data acquired with a multicrystal camera. J Nucl Cardiol 1995; 2: 372-9.
39. Mariano-Goulart D, Collet H, Kotzki PO, Zanca M, Rossi M. Semi-automatic segmentation of gated blood pool emission tomographic images by watersheds:application to the determination of right and left ejection fractions. Eur J Nucl Med 1998; 25: 1300-7.
40. Vanhove C, Franken PR, Defrise M, Momen A, Everaert H, Bossuyt A. Automatic determination of left ventricular ejection fraction from gated blood-pool tomography. J Nucl Med 2001; 42: 401-7.
41. Van Kriekinge SD, Berman DS, Germano G. Automatic quantification of left ventricular ejection fraction from gated blood pool SPECT. J Nucl Cardiol 1999; 6: 498-506.
42. Daou D, Harel F, Helal BO et al. Electrocardiographically gated blood-pool SPECT and left ventricular function: comparative value of 3 methods for ejection fraction and volume estimation. J Nucl Med 2001; 42: 1043-9.
43. Vanhove C, Franken PR. Left ventricular ejection fraction and volumes from gated blood pool tomography: comparison between two automatic algorithms that work in three-dimensional space. J Nucl Cardiol 2001; 8: 466-71.
44. Nichols K, Saouaf R, Ababneh AA et al. Validation of SPECT equilibrium radionuclide angiographic right ventricular parameters by cardiac magnetic resonance imaging. J Nucl Cardiol 2002; 9: 153-60.
45. Wakabayashi T, Nakata T, Hashimoto A et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 2001; 42: 1757-67.
46. Ebina T, Takahashi N, Mitani I et al. Clinical implications of cardiac 123 I-meta-iodobenzylguanidine scintigraphy and cardiac natriuretic peptides in patients with heart disease. Nucl Med Commun 2002; 23: 795-801.
47. Kasama S, Toyama T, Kumakura H et al. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. J Nucl Med 2002; 43: 1279-85.
48. de Milliano PA, de Groot AC, Tijssen JG, van Eck-Smit BL, Van Zwieten PA, Lie KI. Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure. Am Heart J 2002; 144: E3.
49. Kasama S, Toyama T, Hoshizaki H, et al. Dobutamine gated blood pool scintigraphy predicts the improvement of cardiac sympathetic nerve activity, cardiac function, and symptoms after treatment in patients with dilated cardiomyopathy. Chest 2002; 122: 542-8.
50. Schnell O. Cardiac sympathetic innervation and blood flow regulation of the diabetic heart. Diabetes Metab Res Rev 2001; 17: 243-5.
51. Kiyono Y, Iida Y, Kawashima H, Tamaki N, Nishimura H, Saji H. Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes. Eur J Nucl Med 2001; 28: 894-9.
52. Takahashi N, Nakagawa M, Saikawa T et al. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J Am Coll Cardiol 2001; 38: 232-7.
53. Wichter T, Matheja P, Eckardt L et al. Cardiac autonomic dysfunction in Brugada syndrome. Circulation 2002; 105: 702-6.
54. Simula S, Vanninen E, Viitanen L et al. Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease. J Nucl Med 2002; 43: 1-7.
55. Knuuti J, Schelbert HR, Bax JJ. The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2002; 29: 1257-66.
56. Schinkel AF, Box JJ, Sozzi F et al. Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction. Heart 2002; 88: 125-30.
57. Schinkel AF, Bax JJ, Elhendy A et al. Assessment of viable tissue in Q-wave regions by metabolic imaging using single-photon emission computed tomography in ischemic cardiomyopathy. Am J Cardiol 2002; 89: 1171-5.
58. Mabuchi M, Kubo N, Morita K et al. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography, using ultra-high energy collimators for assessing myocardial viability. Nucl Med Commun 2002; 23: 879-85.
59. Brown MA, Semelka RC. MR imaging abbreviations, definitions, and descriptions: a review. Radiology 1999; 213: 647-62.
60. Moon JC, Lorenz CH, Francis JM, Smith GC, Pennell DJ. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. Radiology 2002; 223: 789-97.
61. Miller S, Simonetti OP, Carr J, Kramer U, Finn JP. MR Imaging of the heart with cine true fast imaging with steady-state precession: influence of spatial and temporal resolutions on left ventricular functional parameters. Radiology 2002; 223: 263-9.
62. Barkhausen J, Goyen M, Ruhm SG, Eggebrecht H, Debatin JF, Ladd ME. Assessment of ventricular function with single breath-hold real-time steady-state free precession cine MR imaging. AJR Am J Roentgenol 2002; 178: 731-5.
63. Lee VS, Resnick D, Bundy JM, Simonetti OP, Lee P, Weinreb JC. Cardiac function: MR evaluation in one breath hold with real-time true fast imaging with steady-state precession. Radiology 2002; 222: 835-42.
64. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-53.
65. Simonetti OP, Kim RJ, Fieno DS et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218: 215-23.
66. Zamorano J, Delgado J, Almeria C et al. Reason for discrepancies in identifying myocardial viability by thallium-201 redistribution, magnetic resonance imaging, and dobutamine echocardiography. Am J Cardiol 2002; 90: 455.
67. Brundage BH, Massie BM, Botvinick EH. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol 1984; 3: 902-8.
68. Gunning MG, Kaprielian RR, Pepper J et al. The histology of viable and hibernating myocardium in relation to imaging characteristics. J Am Coll Cardiol 2002; 39: 428-35.
69. Kim RJ, Fieno DS, Parrish TB et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
70. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36: 1985-91.
71. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early, assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000; 102: 1678-83.
72. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001; 104: 1101-7.
73. Klein C, Nekolla SG, Bengel FM et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002; 105: 162-7.
74. Rochitte CE, Lima JA, Bluemke DA et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998; 98: 1006-14.
75. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995; 92: 1117-25.
76. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002; 106: 1083-9.
77. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984; 142: 619-24.
78. Eichenberger AC, Schuiki E, Kochli VD, Amann FW, McKinnon GC, von Schulthess GK. Ischemic heart disease: assessment with gadolinium-enhanced ultrafast MR imaging and dipyridamole stress. J Magn Reson Imaging 1994; 4: 425-31.
79. Dymarkowski S, Ni Y, Miao Y et al. Value of t2-weighted magnetic resonance imaging early after myocardial infarction in dogs: comparison with bis-gadolinium-mesoporphyrin enhanced T1-weighted magnetic resonance imaging and functional data from cine magnetic resonance imaging. Invest Radial 2002; 37: 77-85.
80. Marie PY, Angioi M, Carteaux JP et al. Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol 2001; 37: 825-31.
81. Barkhausen J, Ebert W, Debatin JF, Weinmann HJ. Imaging of myocardial infarction: comparison, of magnevist and gadophrin-3 in rabbits. J Am Coll Cardiol 2002; 39: 1392-8.
82. Ni Y, Pislaru C, Bosmans H et al. Intracoronary delivery of Gd-DTPA and Gadophrin-2 for determination of myocardial viability with MR imaging. Eur Radial 2001; 11: 876-83.
83. Nikolaou K, Huber A, Knez A, Becker C, Bruening R, Reiser M. Intraindividual comparison of contrast-enhanced electron-beam computed tomograghy and navigator-echo-based magnetic resonance imaging for noninvasive coronary artery angiography. Eur Radiol 2002; 12: 1663-71.
84. Ibrahim T, Nekolla SG, Schreiber K et al. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol 2002; 39: 864-70.
85. Wilke N, Jerosch-Herold M, Wang Y et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997; 204: 373-84.
86. Gerber BL, Bluemke DA, Chin BB et al. Single-vessel coronary artery stenosis: myocardial perfusion imaging with Gadomer 17 first-pass MR imaging in a swine model of comparison with gadopentetate dimeglumine. Radiology 2002; 225: 104-12.
87. Panting JR, Gatehouse PD, Yang GZ et al. Abnormal subendocardial perfusion in cardiac synarome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002; 346: 1948-53.
88. Kinney JB, Rovira MJ, Sahn DJ, Lupinetti FM, Gilman MD, Wexler L. MRI of congenital heart disease: a paradigm of collaboration, new suggestions for a team approach from Madigan Army Medical Center. J Cardiovasc Magn Reson 2002; 4: 369-72.
89. Geva T, Greil GF, Marshall AC, Landzberg M, Powell AJ. Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with x-ray angiography. Circulation 2002; 106: 473-8.
90. Tulevski, II, van der Wall EE, Groenink M et al. Usefulness of magnetic resonance imaging dobutamine stress in asymptomatic and minimally symptomatic patients with decreased cardiac reserve from congenital heart disease (complete and corrected transposition of the great arteries and subpulmonic obstruction). Am J Cardiol 2002; 89: 1077-81.
91. Van Der Toorn A, Barenbrug P, Snoep G et al. Transmural gradients of cardiac myofiber shortening in aortic valve stenosis patients using MRI tagging. Am J Physiol Heart Circ Physiol 2002; 283: H1609-H1615.